Dashboard
Manage Tickers

INSM INSMED Inc

Nasdaq insmed.com


$ 161.36 $ -0.69 (-0.43 %)    

Friday, 24-Oct-2025 10:02:25 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 617.36 $ 1.36 (0.22 %)
DIA $ 471.45 $ 1.58 (0.34 %)
SPY $ 677.44 $ 0.96 (0.14 %)
TLT $ 91.28 $ -0.28 (-0.31 %)
GLD $ 377.79 $ -0.86 (-0.23 %)
$ 160.12
$ 161.01
$ 161.10 x 1
$ 161.47 x 1
$ 161.01 - $ 161.98
$ 60.40 - $ 168.22
2,442,223
na
33.85B
$ 0.90
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2025 06-30-2025 10-Q
2 05-08-2025 03-31-2025 10-Q
3 02-20-2025 12-31-2024 10-K
4 10-31-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 02-22-2024 12-31-2023 10-K
8 10-26-2023 09-30-2023 10-Q
9 08-03-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-23-2023 12-31-2022 10-K
12 10-27-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 02-17-2022 12-31-2021 10-K
16 10-28-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 05-06-2021 03-31-2021 10-Q
19 02-25-2021 12-31-2020 10-K
20 10-29-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 04-30-2020 03-31-2020 10-Q
23 02-25-2020 12-31-2019 10-K
24 10-30-2019 09-30-2019 10-Q
25 08-01-2019 06-30-2019 10-Q
26 05-07-2019 03-31-2019 10-Q
27 02-22-2019 12-31-2018 10-K
28 10-30-2018 09-30-2018 10-Q
29 08-02-2018 06-30-2018 10-Q
30 05-02-2018 03-31-2018 10-Q
31 02-23-2018 12-31-2017 10-K
32 11-02-2017 09-30-2017 10-Q
33 08-03-2017 06-30-2017 10-Q
34 05-03-2017 03-31-2017 10-Q
35 02-23-2017 12-31-2016 10-K
36 11-03-2016 09-30-2016 10-Q
37 08-04-2016 06-30-2016 10-Q
38 05-05-2016 03-31-2016 10-Q
39 02-25-2016 12-31-2015 10-K
40 11-06-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

heres-how-much-1000-invested-in-insmed-5-years-ago-would-be-worth-today
Here's How Much $1000 Invested In Insmed 5...
10/23/2025 16:00:35

insmed-says-chmp-recommends-eu-approval-of-brinsupri-brensocatib-for-non-cystic-fibrosis-bronchiectasis-in-patients-12-first-in-class-dpp1-inhibitor-and-first-eu-therapy-for-ncfb
Insmed Says CHMP Recommends EU Approval Of...
10/17/2025 11:10:53

insmed-to-present-six-abstracts-from-phase-3-aspen-study-of-brinsupri-at-chest-2025
Insmed To Present Six Abstracts From Phase...
10/16/2025 11:04:17

—Data on Structural Lung Changes from a High-Resolution CT Substudy to be Presented as Late-Breaker——Additional Analyses Will H...

this-is-what-whales-are-betting-on-insmed
This Is What Whales Are Betting On Insmed
10/15/2025 19:02:07

ubs-maintains-buy-on-insmed-raises-price-target-to-194
UBS Maintains Buy on Insmed, Raises Price ...
10/14/2025 16:02:17

UBS analyst Trung Huynh maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $140 to $194.

heres-how-much-1000-invested-in-insmed-10-years-ago-would-be-worth-today
Here's How Much $1000 Invested In Insmed 1...
10/07/2025 15:30:35

goldman-sachs-maintains-buy-on-insmed-raises-price-target-to-196
Goldman Sachs Maintains Buy on Insmed, Rai...
10/03/2025 16:59:31

Goldman Sachs analyst Andrea Tan maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $121 to $196.

analyst-expectations-for-insmeds-future
Analyst Expectations For Insmed's Future
10/02/2025 18:00:52

td-cowen-maintains-buy-on-insmed-raises-price-target-to-193
TD Cowen Maintains Buy on Insmed, Raises P...
10/02/2025 14:06:47

TD Cowen analyst Ritu Baral maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $154 to $193.

6-stocks-goldman-sachs-says-are-poised-for-potential-acquisition-in-next-12-months--including-a-huge-200-winner
6 Stocks Goldman Sachs Says Are Poised For...
09/30/2025 13:11:43

Goldman Sachs has highlighted six stocks that have a high probability of being acquisition targets in the next year.

spotlight-on-insmed-analyzing-the-surge-in-options-activity
Spotlight on Insmed: Analyzing the Surge i...
09/25/2025 19:01:31

Financial giants have made a conspicuous bearish move on Insmed. Our analysis of options history for Insmed (NASDAQ: INSM) reve...

heres-how-much-100-invested-in-insmed-10-years-ago-would-be-worth-today
Here's How Much $100 Invested In Insmed 10...
09/22/2025 14:32:18

insmed-to-present-seven-abstracts-from-across-its-late-stage-portfolio-at-ers-2025-congress
Insmed To Present Seven Abstracts From Acr...
09/22/2025 11:13:04

—Data from Phase 2b Study of Treprostinil Palmitil Inhalation Powder in Patients with Pulmonary Arterial Hypertension to be Pre...

Core News & Articles
10 Health Care Stocks Whale Activity In To...
09/09/2025 17:35:29

guggenheim-maintains-buy-on-insmed-raises-price-target-to-172
Guggenheim Maintains Buy on Insmed, Raises...
09/08/2025 13:41:38

Guggenheim analyst Vamil Divan maintains Insmed (NASDAQ:INSM) with a Buy and raises the price target from $125 to $172.

deep-dive-into-insmed-stock-analyst-perspectives-26-ratings
Deep Dive Into Insmed Stock: Analyst Persp...
09/03/2025 19:01:05

wells-fargo-maintains-overweight-on-insmed-raises-price-target-to-171
Wells Fargo Maintains Overweight on Insmed...
09/03/2025 12:56:34

Wells Fargo analyst Tiago Fauth maintains Insmed (NASDAQ:INSM) with a Overweight and raises the price target from $140 to $171.

air-lease-ionis-pharmaceuticals-arrowhead-pharmaceuticals-and-other-big-stocks-moving-higher-on-tuesday
Air Lease, Ionis Pharmaceuticals, Arrowhea...
09/02/2025 14:41:45

israel-englanders-millennium-goes-all-in-on-crypto-and-healthcare-while-rebalancing-big-tech-bets-bitcoin-etf-and-palantir-stakes-soar-in-q2
Israel Englander's Millennium Goes All-In ...
08/27/2025 07:07:43

Millennium Management's Q2 2025 13F reveals big bets on crypto (IBIT, PLTR) & healthcare (EW, INSM), with tech rebalanc...

1000-invested-in-insmed-10-years-ago-would-be-worth-this-much-today
$1000 Invested In Insmed 10 Years Ago Woul...
08/21/2025 14:00:26

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION